Results 201 to 210 of about 76,441 (354)

A phase 1, multicenter, open‐label study to evaluate the pharmacokinetics, safety, and tolerability of a single dose of rimegepant in children (aged ≥6 to <12 years) with a history of migraine

Headache: The Journal of Head and Face Pain, EarlyView.
Abstract Objective To evaluate pharmacokinetics (PK), safety, and tolerability of a weight‐adjusted dose of rimegepant orally disintegrating tablet (ODT) in children (aged ≥6 to <12 years) with a history of migraine. Background Rimegepant 75 mg ODT is approved for acute treatment of migraine (with or without aura) and preventive treatment of episodic ...
Chay Ngee Lim, Gary Mo, Rajinder Bhardwaj, Craig M. Comisar, Beth L. Emerson, Kyle T. Matschke, Ogert Fisniku, Richard Bertz, Robert Croop, Jing Liu   +9 more
wiley   +1 more source

Psychometric Validation of the Arabic Version of the WPAI:Migraine Questionnaire in Patients with Migraine. [PDF]

Neurol Int
Albilali A, Almutawa RA, Almusahel EA, Almutawa RA, Almutawa NA, Almutawa FM, AlAujan S, AlMalag HM.   +7 more
europepmc   +1 more source

An investigation of the extent of teacher absenteeism and the implementation of selected teacher absence control techniques

, 1982
Linda Turner Hornback
openalex   +1 more source

OnabotulinumtoxinA treatment among diverse racial groups: Post hoc analysis of the phase 4 Chronic migraine OnabotulinuMtoxinA Prolonged Efficacy open‐Label (COMPEL) trial

Headache: The Journal of Head and Face Pain, EarlyView.
Abstract Objective Examine treatment responses to and safety of onabotulinumtoxinA for the preventive treatment of chronic migraine (CM) among diverse racial groups. Background Evidence suggests there are differences in headache treatment patterns, symptom profiles, and burden based on race.
Andrew M. Blumenfeld, Larry Charleston IV, Deena Kuruvilla, Belinda Savage‐Edwards, Richard B. Lipton, Ritu Singh, Patricia Jacob, Nicole A. Lawrence, Cuiwei Wang, Hope L. O'Brien   +9 more
wiley   +1 more source

Cardiovascular disease and absenteeism in Dutch occupational health: a retrospective study in a regular working population. [PDF]

Neth Heart J
van Dongen IM, Winter J, Aben B, Wijntjens GWM, Delewi R, Siebers J, Kok RN, Schaafsma FG.   +7 more
europepmc   +1 more source

Minimal Disease Activity as A New Therapeutic Target in Atopic Dermatitis: A 5‐Year Real‐Life Experience With Dupilumab

International Journal of Dermatology, EarlyView.
ABSTRACT Background Atopic dermatitis (AD) is a chronic inflammatory skin disease with significant physical and psychosocial burden. Dupilumab, a monoclonal antibody targeting IL‐4Rα, has proven to be effective for moderate‐to‐severe AD, but long‐term real‐world data remain limited.
Francesco Leo, Luca Mastorino, Luca Cangialosi, Davide Favre, Chiara Anna Fiasconaro, Yingying Liao, Federico Goso, Niccolò Siliquini, Giovanni Cavaliere, Pietro Quaglino, Simone Ribero, Michela Ortoncelli   +11 more
wiley   +1 more source

Early Predictors of School Absenteeism in First-Grade Children: A Multidimensional Longitudinal Study in Japan. [PDF]

Children (Basel)
Soma Y, Ogasawara Y, Kobayashi H.
europepmc   +1 more source

Industrial Sickness Absenteeism [PDF]

Public Health Reports (1896-1970), 1952
openaire   +3 more sources

Development and validation of a premenstrual symptom screening tool for working women in relation to absenteeism. [PDF]

BMC Womens Health
Takenoshita C, Shimizu K, Iida M, Taka F, Maeda E, Jung S, Nomura K.   +6 more
europepmc   +1 more source

Absenteeism, an indicator of the health status of school children in the middle schools of the Molopo region in the North-West Province

, 1995
Maria Molebogeng Hlonipho
openalex   +1 more source